Figure 2.Overall survival and time to recurrence are shown for patients with HCC. All patients were classified according to tumor size, vascular invasion, TNM stage and BCLC stage. Kaplan-Meier survival estimates and log-rank tests were used to analyze the prognostic value of HOXC6 expression in all patients (A) and each subgroup (B-I).
